1. Home
  2. KRYS vs ZETA Comparison

KRYS vs ZETA Comparison

Compare KRYS & ZETA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KRYS
  • ZETA
  • Stock Information
  • Founded
  • KRYS 2015
  • ZETA 2007
  • Country
  • KRYS United States
  • ZETA United States
  • Employees
  • KRYS N/A
  • ZETA N/A
  • Industry
  • KRYS Biotechnology: Biological Products (No Diagnostic Substances)
  • ZETA EDP Services
  • Sector
  • KRYS Health Care
  • ZETA Technology
  • Exchange
  • KRYS Nasdaq
  • ZETA Nasdaq
  • Market Cap
  • KRYS 4.3B
  • ZETA 3.5B
  • IPO Year
  • KRYS 2017
  • ZETA 2021
  • Fundamental
  • Price
  • KRYS $150.49
  • ZETA $19.56
  • Analyst Decision
  • KRYS Strong Buy
  • ZETA Strong Buy
  • Analyst Count
  • KRYS 10
  • ZETA 15
  • Target Price
  • KRYS $204.90
  • ZETA $28.36
  • AVG Volume (30 Days)
  • KRYS 422.6K
  • ZETA 11.1M
  • Earning Date
  • KRYS 08-04-2025
  • ZETA 08-05-2025
  • Dividend Yield
  • KRYS N/A
  • ZETA N/A
  • EPS Growth
  • KRYS 36.22
  • ZETA N/A
  • EPS
  • KRYS 4.91
  • ZETA N/A
  • Revenue
  • KRYS $359,205,000.00
  • ZETA $1,155,829,000.00
  • Revenue This Year
  • KRYS $34.33
  • ZETA $25.88
  • Revenue Next Year
  • KRYS $47.84
  • ZETA $17.38
  • P/E Ratio
  • KRYS $30.77
  • ZETA N/A
  • Revenue Growth
  • KRYS 116.08
  • ZETA 40.60
  • 52 Week Low
  • KRYS $122.80
  • ZETA $10.69
  • 52 Week High
  • KRYS $207.84
  • ZETA $38.20
  • Technical
  • Relative Strength Index (RSI)
  • KRYS 56.41
  • ZETA 61.58
  • Support Level
  • KRYS $142.51
  • ZETA $17.38
  • Resistance Level
  • KRYS $147.58
  • ZETA $19.99
  • Average True Range (ATR)
  • KRYS 4.78
  • ZETA 1.22
  • MACD
  • KRYS 0.39
  • ZETA 0.01
  • Stochastic Oscillator
  • KRYS 92.81
  • ZETA 73.16

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

About ZETA Zeta Global Holdings Corp.

Zeta Global Holdings Corp is an omnichannel data-driven cloud platform that provides enterprises with consumer intelligence and marketing automation software. It serves enterprise customers across multiple industries, including financial services, insurance, telecommunications, automotive, travel and hospitality, and retail. Its Zeta Marketing Platform, or ZMP, is an omnichannel marketing platform with identity data at its core. The ZMP can analyze billions of structured and unstructured data points to predict consumer intent by leveraging sophisticated machine learning algorithms and the industry's opted-in data set for omnichannel marketing.

Share on Social Networks: